ボストン--(BUSINESS WIRE)--米国ボストン・ストラテジクス社は、米国ＭＤアンダーソンがんセンターと画期的なリスクシェア契約を締結。急性骨髄性白血病を含む進行血液がんの患者さんを対象としたE6201の第１/２a相臨床試験をＭＤアンダーソンがんセンターにて実施。新しい治療法を待ち望む進行性血液がん患者さんへのアンメットニーズに応えるという志をパートナーと共有し、困難な新薬開発の道を共に歩む。
| < Prev | Next > |
|---|
- Magazine seeks writers for online column in U.S.A, U.K., Asia & Australia. Writers wanted
- Hunt for Queen's Wharf developer commences
- Queensland unit and townhouse sales climb
- Perth median house price at new record
- Don’t let a bad credit score ruin your chances of a home loan
- The Importance of Communication for Business Success
- Businesses
- Respected local restaurateurs are the icing on the Tweed River Art Gallery
- Lonely Planet names Kimberley as world’s second top tourism region for 2014
- The Workers Launch Balmain's Biggest Laugh Free Live Comedy
- UK Innovator Visa: Getting Endorsement
- Katter calls for better delivery of drought assistance
- Jazz Degustation + The Cellar Jazz Jam
- Surplus signals time for NSW Government to cut stamp duty
- The Global Forest Industry This Quarter
- Record harvest ensures city fruit and veg supplies
